BTDAzo: A Photoswitchable TRPC5 Channel Activator

Photoswitchable reagents can be powerful tools for high‐precision biological control. TRPC5 is a Ca2+‐permeable cation channel with distinct tissue‐specific roles, from synaptic function to hormone regulation. Reagents giving spatiotemporally‐resolved control over TRPC5 activity may be key to unders...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Angewandte Chemie International Edition 2022-09, Vol.61 (36), p.e202201565-n/a
Hauptverfasser: Müller, Markus, Niemeyer, Konstantin, Urban, Nicole, Ojha, Navin K., Zufall, Frank, Leinders‐Zufall, Trese, Schaefer, Michael, Thorn‐Seshold, Oliver
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Photoswitchable reagents can be powerful tools for high‐precision biological control. TRPC5 is a Ca2+‐permeable cation channel with distinct tissue‐specific roles, from synaptic function to hormone regulation. Reagents giving spatiotemporally‐resolved control over TRPC5 activity may be key to understanding and harnessing its biology. Here we develop the first photoswitchable TRPC5‐modulator, BTDAzo, to address this goal. BTDAzo can photocontrol TRPC5 currents in cell culture, as well as controlling endogenous TRPC5‐based neuronal Ca2+ responses in mouse brain slices. BTDAzos are also the first reported azo‐benzothiadiazines, an accessible and conveniently derivatised azoheteroarene with strong two‐colour photoswitching. BTDAzo′s ability to control TRPC5 across relevant channel biology settings makes it suitable for a range of dynamically reversible photoswitching studies in TRP channel biology, with the aim to decipher the various biological roles of this centrally important ion channel. The TRPs (Transient Receptor Potentials) are important sensory ion channels with roles in perception including of heat, cold, and electrophiles, as well as in signaling and mineralostasis. Here the first photopharmaceutical TRPC5 ligand, BTDAzo, is developed, which achieves outstanding photoswitchability of TRPC5 currents in physiological models including brain slice, without crosstalk to the related TRPC4 channel.
ISSN:1433-7851
1521-3773
1521-3773
DOI:10.1002/anie.202201565